scispace - formally typeset
P

Päivi Laaksonen

Researcher at Aalto University

Publications -  52
Citations -  2604

Päivi Laaksonen is an academic researcher from Aalto University. The author has contributed to research in topics: Hydrophobin & Nanocellulose. The author has an hindex of 21, co-authored 48 publications receiving 2179 citations. Previous affiliations of Päivi Laaksonen include Saarland University & VTT Technical Research Centre of Finland.

Papers
More filters
Journal ArticleDOI

Advanced Materials through Assembly of Nanocelluloses.

TL;DR: There is an emerging quest for lightweight materials with excellent mechanical properties and economic production, while still being sustainable and functionalizable, which could form the basis of the future bio economy for energy and material efficiency.
Journal ArticleDOI

Drug release from nanoparticles embedded in four different nanofibrillar cellulose aerogels

TL;DR: It is shown that beclomethasone dipropionate (BDP) nanoparticles coated with amphiphilic hydrophobin proteins can be well integrated into the NFC aerogels and modulation of the matrix formers enable a control of the drug release rate.
Journal ArticleDOI

Interfacial engineering by proteins: exfoliation and functionalization of graphene by hydrophobins

TL;DR: This work presents a method for the exfoliation and functionalization of graphene sheets by an amphiphilic protein, which belongs to a class of proteins called hydrophobins that interacts strongly with hydrophobic surfaces, such as graphite and silicon.
Journal ArticleDOI

Genetic Engineering of Biomimetic Nanocomposites: Diblock Proteins, Graphene, and Nanofibrillated Cellulose

TL;DR: This work shows the feasibility of genetically engineered proteins having two well-defined binding blocks, denoted as diblock proteins, that bind and assemble the structural components for biomimetic composites.
Journal ArticleDOI

Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices--enhanced stability and release.

TL;DR: It was demonstrated that by enclosing the functionalized protein coated itraconazole nanoparticles to the external nanofibrillar cellulose matrix notably increased their storage stability and enhanced the in vivo performance of the drug.